Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

BACKGROUND: Population-based studies suggest that emergency department visits and hospitalizations are common among patients receiving chemotherapy and that rates in routine practice are higher than expected from clinical trials. Chemotherapy-related toxicities are often predictable and, consequentl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Krzyzanowska, Monika K., Julian, Jim A., Powis, Melanie, Howell, Doris, Earle, Craig C., Enright, Katherine A., Mittmann, Nicole, Trudeau, Maureen E., Grunfeld, Eva
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729066/
https://ncbi.nlm.nih.gov/pubmed/31488084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6099-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky